Cargando…
Cost-effectiveness of an insertable cardiac monitor in a high-risk population in the US
BACKGROUND: Insertable cardiac monitors (ICMs) are a clinically effective means of detecting atrial fibrillation (AF) in high-risk patients, and guiding the initiation of non-vitamin K oral anticoagulants (NOACs). Their cost-effectiveness from a US clinical payer perspective is not yet known. The ob...
Autores principales: | Elkind, Mitchell S. V., Witte, Klaus K., Kasner, Scott E., Sawyer, Laura M., Grimsey Jones, Frank W., Rinciog, Claudia, Tsintzos, Stelios, Rosemas, Sarah C., Lanctin, David, Ziegler, Paul D., Reynolds, Matthew R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9875401/ https://www.ncbi.nlm.nih.gov/pubmed/36698055 http://dx.doi.org/10.1186/s12872-023-03073-6 |
Ejemplares similares
-
Cost-effectiveness of an insertable cardiac monitor in a high-risk population in the UK
por: Rinciog, Claudia I, et al.
Publicado: (2019) -
Economic value of insertable cardiac monitors in unexplained syncope in the United States
por: Sutton, Brad S, et al.
Publicado: (2021) -
Impact of novel insertable cardiac monitoring system on real-world cardiac device clinic workflow
por: Rosemas, S C, et al.
Publicado: (2023) -
Healthcare utilization and clinical outcomes after ablation of atrial fibrillation in patients with and without insertable cardiac monitoring
por: Mansour, Moussa C., et al.
Publicado: (2022) -
Diagnostic sensitivity and cost per diagnosis of ambulatory cardiac monitoring strategies in unexplained syncope patients
por: Rogers, John D., et al.
Publicado: (2022)